Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Bulletin Du Cancer|September 6, 2003
[Passive immunotherapy of melanoma]Francine Jotereau, Nathalie Labarriere, Nadine Gervois, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 8, 2002
Expression of CD94/NKG2-A on human T lymphocytes is induced by IL-12: implications for adoptive immunotherapyLaurent Derre, Murielle Corvaisier, Marie-Christine Pandolfino, et al.
Experimental Dermatology|March 6, 2018
PD-L1 expression by tumor cell lines: A predictive marker in melanomaAnne C Knol, Jean-Michel Nguyen, Marie-Christine Pandolfino, et al.
Cancer Immunology, Immunotherapy : CII|October 18, 2002
Therapeutic efficacy of melanoma-reactive TIL injected in stage III melanoma patientsNathalie Labarrière, Marie-Christine Pandolfino, Nadine Gervois, et al.
Journal of the American Academy of Dermatology|October 26, 2005
CD8(+) T lymphocytes reactive against Epstein-Barr virus antigens in skin lesions of a patient with Sézary syndromeAnne-Chantal Knol, Yannick Guilloux, Gaëlle Quéreux, et al.
European Journal of Dermatology : EJD|June 2, 2007
Tissue prognostic markers for adoptive immunotherapy in melanomaGaëlle Quereux, Marie-Christine Pandolfino, Anne-Chantal Knol, et al.
The Journal of Pathology|December 20, 2008
Defective activations of STAT3 Ser727 and PKC isoforms lead to oncostatin M resistance in metastatic melanoma cellsA Lacreusette, Isabelle Barbieux, Jean-Michel Nguyen, et al.
Cancer Immunology, Immunotherapy : CII|July 29, 2006
Infusion of Melan-A/Mart-1 specific tumor-infiltrating lymphocytes enhanced relapse-free survival of melanoma patientsHoussem Benlalam, Virginie Vignard, Amir Khammari, et al.
Experimental Dermatology|March 4, 2008
Absence of amplification of CD4+CD25(high) regulatory T cells during in vitro expansion of tumor-infiltrating lymphocytes in melanoma patientsAnne Chantal Knol, Fabrice Lemaître, Marie Christine Pandolfino, et al.
Experimental Dermatology|November 4, 2014
Comparative analysis of BRAF, NRAS and c-KIT mutation status between tumor tissues and autologous tumor cell-lines of stage III/IV melanomaAnne-Chantal Knol, Marie-Christine Pandolfino, Audrey Vallée, et al.
Pageof 2